Stay updated on SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial
Sign up to get notified when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.

Latest updates to the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page
- Check6 days agoChange DetectedThe page shows a newer revision build (v3.6.2) replacing the previous v3.6.0, reflecting a minor update to the page's backend or rendering without altering study information.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedRecruitment status changed to 'No longer looking for participants,' indicating no further enrollment. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and there were minor formatting changes to the Intervention/Treatment heading along with a revision tag update to v3.6.0.SummaryDifference0.4%

- Check27 days agoChange DetectedThe revision label on the page updated from v3.5.4 to v3.5.5, indicating a newer page version. No changes to study details or results are implied by this update.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page’s revision label updated to v3.5.4, signaling a recent maintenance/update to the study entry. This reflects a version update rather than a change to the study data itself.SummaryDifference0.1%

- Check62 days agoChange DetectedThe status in the results section changed from 'No Results Posted' to 'Results Submitted', signaling that the study results have been submitted to the registry.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, indicating a version change for the site/renderer rather than a change to the study record.SummaryDifference0.1%

Stay in the know with updates to SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.